U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Sold by Two Sigma Investments LP

Two Sigma Investments LP lowered its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 24.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 40,201 shares of the company's stock after selling 12,952 shares during the period. Two Sigma Investments LP owned 0.27% of U.S. Physical Therapy worth $3,566,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of the stock. Lazard Asset Management LLC purchased a new stake in shares of U.S. Physical Therapy during the 4th quarter valued at $84,000. Wells Fargo & Company MN lifted its holdings in shares of U.S. Physical Therapy by 2.2% during the 4th quarter. Wells Fargo & Company MN now owns 112,959 shares of the company's stock valued at $10,021,000 after purchasing an additional 2,465 shares during the last quarter. Deutsche Bank AG lifted its holdings in shares of U.S. Physical Therapy by 49.3% during the 4th quarter. Deutsche Bank AG now owns 13,176 shares of the company's stock valued at $1,169,000 after purchasing an additional 4,350 shares during the last quarter. PNC Financial Services Group Inc. lifted its holdings in shares of U.S. Physical Therapy by 37.4% during the 4th quarter. PNC Financial Services Group Inc. now owns 4,605 shares of the company's stock valued at $409,000 after purchasing an additional 1,254 shares during the last quarter. Finally, Copeland Capital Management LLC lifted its holdings in shares of U.S. Physical Therapy by 9.5% during the 4th quarter. Copeland Capital Management LLC now owns 839,356 shares of the company's stock valued at $74,459,000 after purchasing an additional 72,715 shares during the last quarter.

U.S. Physical Therapy Stock Performance

USPH traded down $0.10 during midday trading on Tuesday, hitting $74.09. 146,364 shares of the company were exchanged, compared to its average volume of 111,854. The company's 50 day simple moving average is $72.07 and its 200 day simple moving average is $82.42. The firm has a market capitalization of $1.13 billion, a price-to-earnings ratio of 78.82, a price-to-earnings-growth ratio of 3.54 and a beta of 1.44. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy, Inc. has a 1-year low of $62.77 and a 1-year high of $101.20.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported $0.48 EPS for the quarter, beating analysts' consensus estimates of $0.46 by $0.02. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The firm had revenue of $183.79 million for the quarter, compared to analysts' expectations of $176.78 million. During the same period last year, the firm earned $0.51 EPS. The company's quarterly revenue was up 18.0% on a year-over-year basis. As a group, sell-side analysts predict that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 23rd will be given a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.43%. The ex-dividend date is Friday, May 23rd. U.S. Physical Therapy's dividend payout ratio (DPR) is presently 82.57%.

Insider Activity

In related news, COO Graham D. Reeve sold 1,730 shares of U.S. Physical Therapy stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the sale, the chief operating officer now directly owns 7,168 shares in the company, valued at approximately $588,564.48. The trade was a 19.44% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 2.00% of the company's stock.

Analysts Set New Price Targets

Several brokerages have recently commented on USPH. JPMorgan Chase & Co. decreased their price objective on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Wednesday, March 19th. William Blair reissued a "market perform" rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. Barrington Research cut their target price on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a research report on Friday, February 28th. Wall Street Zen raised U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Thursday, May 8th. Finally, JMP Securities reissued a "market outperform" rating and issued a $113.00 target price on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $109.00.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.